FOXO-Dri

FOXO4-DRI FOXO4-DRI is a synthetic research peptide derived from the forkhead box O4 (FOXO4) transcription factor. This peptide has been developed to selectively interfere with the interaction between FOXO4 and p53, two proteins heavily involved in cellular stress responses, senescence, and apoptosis. By disrupting the FOXO4–p53 interaction, FOXO4-DRI allows researchers to study pathways related to cellular aging and the clearance of senescent cells. Because senescent cells can accumulate with age and stress, this peptide has become a valuable tool in scientific studies on longevity, regenerative biology, and age-associated conditions. Potential Research Benefits: • Study of cellular senescence and programmed cell death (apoptosis) • Investigation of FOXO4–p53 protein interactions • Exploration of anti-aging and longevity-related mechanisms • Research on tissue regeneration and cell renewal pathways Product Details: • Contents: 10mg FOXO4-DRI peptide per vial • Purity: ≥98% (HPLC tested) • Form: Lyophilized powder • Appearance: White/off-white crystalline powder • Storage: Store lyophilized at –20°C; after reconstitution keep refrigerated (2–8°C) • Usage: For laboratory and scientific research only. Not for human consumption. Key Features: • High-purity, research-grade FOXO4 peptide • Sealed, sterile vial for maximum stability • Designed for advanced studies in cellular biology, senescence, and longevity science